On the ABO results conference & signature ceremony held on October 20, Acorn Compus and AutekBio (Beijing) signed the Series B Investment Agreement. This round, sized at US$3M, will be led by Acorn Compus, with the participation of Ganquan Life Investment and Pacific Rim.
AutekBio (Beijing), registered in the Silicon Valley, is a wholly funded enterprise. With the main businesses including independent research, contract R&D and production, the enterprise aims to enhance the research level of domestic biological products and establish a high-level biological products R&D and production base, with the foreign advanced biological technology.
